PartsTable
Technical Data Sheet
Download PDF

NDC00113-2023-60 — GUAIFENESIN EXTENDED-RELEASE TAB

✓ Government record, cited
— · COMPONENT
PRODUCT OVERVIEW

NDC00113-2023-60: GUAIFENESIN EXTENDED-RELEASE TAB.

GUAIFENESIN EXTENDED-RELEASE TAB. Key specifications include administration: ORAL, special_features: PRESERVE IN TIGHT CONTAINER, long_action_method: EXTENDED RELEASE, primary_container_type: BOTTLE, protective_storage_feature: CONTROLLED ROOM TEMPERATURE AND EXPIRATION DATED, primary_container_content_quantity: 20.000 TABLETS. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-539-3176, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS
NDC00113-2023-60
NSN: 6505-01-539-3176
FSC: 6505 — Drugs and Biologicals
CAGE: 9MGE4 — PADAGIS US LLC DBA PERRIGO MINNESOTA (USA)
SPECIFICATIONS
administrationORAL
special_featuresPRESERVE IN TIGHT CONTAINER
long_action_methodEXTENDED RELEASE
primary_container_typeBOTTLE
protective_storage_featureCONTROLLED ROOM TEMPERATURE AND EXPIRATION DATED
primary_container_content_quantity20.000 TABLETS
active_medicament_medicinal_strength600.000 MILLIGRAMS GUAIFENESIN ACTIVE INGREDIENT
part_name_assigned_by_controlling_agencyGUAIFENESIN EXTENDED RELEASE TABLETS 600MG BT 20S
american_hospital_formulary_service_classification_number481600
NSN6505-01-539-3176
COMPONENT DIAGRAM
COMPONENT MAIN IC EDGE CONNECTOR No detailed specs available GUAIFENESIN EXTENDED-RELEASE TAB TITLE COMPONENT PN NDC00113-2023-60 MFR GUAIFENESIN EXTENDED-R
KEY FEATURES
•
LONG ACTION METHOD: EXTENDED RELEASE
•
ADMINISTRATION: ORAL
•
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 TABLETS
•
PRIMARY CONTAINER TYPE: BOTTLE
•
PROTECTIVE STORAGE FEATURE: CONTROLLED ROOM TEMPERATURE AND EXPIRATION DATED
•
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 481600
TECHNICAL CHARACTERISTICS
LONG ACTION METHODEXTENDED RELEASE
ADMINISTRATIONORAL
PRIMARY CONTAINER CONTENT QUANTITY20.000 TABLETS
PRIMARY CONTAINER TYPEBOTTLE
SPECIAL FEATURESPRESERVE IN TIGHT CONTAINER
PROTECTIVE STORAGE FEATURECONTROLLED ROOM TEMPERATURE AND EXPIRATION DATED
PART NAME ASSIGNED BY CONTROLLING AGENCYGUAIFENESIN EXTENDED RELEASE TABLETS 600MG BT 20S
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER481600
ACTIVE MEDICAMENT MEDICINAL STRENGTH600.000 MILLIGRAMS GUAIFENESIN ACTIVE INGREDIENT
SUBSTITUTES & CROSS-REFERENCES 3
MUCINEXReference document
Same NSN cross-reference
Reference document — Secondary reference
NDC63824-0008-32Reference document
Same NSN cross-reference
Reference document — Secondary reference
06-0266Reference document
Same NSN cross-reference
Reference document — Secondary reference
LIFECYCLE
NSN statusActive· U.S. Government catalog
Shelf-life managedNo demilitarization required
Ready to buy NDC00113-2023-60?
Compare prices from verified sellers on eBay
Buy on eBay →
As an eBay Partner, PartsTable may earn a commission. Your price is not affected.
FREQUENTLY ASKED QUESTIONS
What is NDC00113-2023-60?
NDC00113-2023-60 is a GUAIFENESIN EXTENDED-RELEASE TAB.
What parts can replace NDC00113-2023-60?
There are 3 known substitutes for NDC00113-2023-60: MUCINEX, NDC63824-0008-32, 06-0266. Substitute compatibility should be verified for your specific system.
What is the NSN for NDC00113-2023-60?
NDC00113-2023-60 is cataloged in the U.S. Government catalog under NSN 6505-01-539-3176. This indicates validated use in U.S. government and defense supply chains.
Community Feedback
Leave a Comment
Comments are reviewed before appearing. You will receive an email to verify before your comment appears.

Request a Quote — NDC00113-2023-60